Genetic engineering in organoids

J Mol Med (Berl). 2021 Apr;99(4):555-568. doi: 10.1007/s00109-020-02029-z. Epub 2021 Jan 18.

Abstract

Three-dimensional organoids have been widely used for developmental and disease modeling. Organoids are derived from both adult and pluripotent stem cells. Various types are available for mimicking almost all major organs and tissues in the mouse and human. While culture protocols for stepwise differentiation and long-term expansion are well established, methods for genetic manipulation in organoids still need further standardization. In this review, we summarized different methods for organoid genetics and provide the pros and cons of each method for designing an optimal strategy.

Keywords: 3D Organoids; Adult Stem Cells; CRISPR/Cas9; Disease Modeling; Genetic Engineering; Organoid Genetics; Pluripotent Stem Cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adult Stem Cells / cytology
  • Adult Stem Cells / drug effects
  • Animals
  • Animals, Genetically Modified
  • Brain / cytology
  • CRISPR-Cas Systems
  • Cellular Reprogramming Techniques
  • Gastrointestinal Tract / cytology
  • Gene Editing / methods
  • Gene Transfer Techniques
  • Genetic Engineering / methods*
  • Genetic Engineering / trends
  • Humans
  • Induced Pluripotent Stem Cells / cytology
  • Induced Pluripotent Stem Cells / drug effects
  • Kidney / cytology
  • Liver / cytology
  • Mammary Glands, Animal / cytology
  • Mice
  • Organoids* / cytology